Stability enhancing N-terminal PEGylation of oxytocin exploiting different polymer architectures and conjugation approaches

Jennifer Collins, Kristian Kempe, Paul Wilson, Claudia A. Blindauer, Michelle P. McIntosh, Thomas P. Davis, Michael R. Whittaker, David M. Haddleton

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Oxytocin, a cyclic nine amino acid neurohypophyseal hormone therapeutic, is effectively used in the control of postpartum hemorrhaging (PPH) and is on the WHO List of Essential Medicines. However, oxytocin has limited shelf life stability in aqueous solutions, particularly at temperatures in excess of 25 °C and injectable aqueous oxytocin formulations require refrigeration (<8 °C). This is particularly problematic in the hot climates often found in many developing countries where daytime temperatures can exceed 40 °C and where reliable cold-chain storage is not always achievable. The purpose of this study was to develop N-terminal amine targeted PEGylation strategies utilizing both linear PEG and polyPEG "comb" polymers as an effective method for stabilizing solution formulations of this peptide for prolonged storage in the absence of efficient cold-chain storage. The conjugation chemistries investigated herein include irreversible amine targeted conjugation methods utilizing NHS ester and aldehyde reductive amination chemistry. Additionally, one reversible conjugation method using a Schiff base approach was explored to allow for the release of the native peptide, thus, ensuring that biological activity remains unaffected. The reversibility of this approach was investigated for the different polymer architectures, alongside a nonpolymer oxytocin analogue to monitor how pH can tune native peptide release. Elevated temperature degradation studies of the polymer conjugates were evaluated to assess the stability of the PEGylated analogues in comparison to the native peptide in aqueous formulations to mimic storage conditions in developing nations and regions where storage under appropriate conditions is challenging.

Original languageEnglish
Pages (from-to)2755-2766
Number of pages12
JournalBiomacromolecules
Volume17
Issue number8
DOIs
Publication statusPublished - 8 Aug 2016

Cite this

@article{f60a66fe62fc4149818b17db52a6bf38,
title = "Stability enhancing N-terminal PEGylation of oxytocin exploiting different polymer architectures and conjugation approaches",
abstract = "Oxytocin, a cyclic nine amino acid neurohypophyseal hormone therapeutic, is effectively used in the control of postpartum hemorrhaging (PPH) and is on the WHO List of Essential Medicines. However, oxytocin has limited shelf life stability in aqueous solutions, particularly at temperatures in excess of 25 °C and injectable aqueous oxytocin formulations require refrigeration (<8 °C). This is particularly problematic in the hot climates often found in many developing countries where daytime temperatures can exceed 40 °C and where reliable cold-chain storage is not always achievable. The purpose of this study was to develop N-terminal amine targeted PEGylation strategies utilizing both linear PEG and polyPEG {"}comb{"} polymers as an effective method for stabilizing solution formulations of this peptide for prolonged storage in the absence of efficient cold-chain storage. The conjugation chemistries investigated herein include irreversible amine targeted conjugation methods utilizing NHS ester and aldehyde reductive amination chemistry. Additionally, one reversible conjugation method using a Schiff base approach was explored to allow for the release of the native peptide, thus, ensuring that biological activity remains unaffected. The reversibility of this approach was investigated for the different polymer architectures, alongside a nonpolymer oxytocin analogue to monitor how pH can tune native peptide release. Elevated temperature degradation studies of the polymer conjugates were evaluated to assess the stability of the PEGylated analogues in comparison to the native peptide in aqueous formulations to mimic storage conditions in developing nations and regions where storage under appropriate conditions is challenging.",
author = "Jennifer Collins and Kristian Kempe and Paul Wilson and Blindauer, {Claudia A.} and McIntosh, {Michelle P.} and Davis, {Thomas P.} and Whittaker, {Michael R.} and Haddleton, {David M.}",
year = "2016",
month = "8",
day = "8",
doi = "10.1021/acs.biomac.6b00919",
language = "English",
volume = "17",
pages = "2755--2766",
journal = "Biomacromolecules",
issn = "1525-7797",
publisher = "American Chemical Society (ACS)",
number = "8",

}

Stability enhancing N-terminal PEGylation of oxytocin exploiting different polymer architectures and conjugation approaches. / Collins, Jennifer; Kempe, Kristian; Wilson, Paul; Blindauer, Claudia A.; McIntosh, Michelle P.; Davis, Thomas P.; Whittaker, Michael R.; Haddleton, David M.

In: Biomacromolecules, Vol. 17, No. 8, 08.08.2016, p. 2755-2766.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Stability enhancing N-terminal PEGylation of oxytocin exploiting different polymer architectures and conjugation approaches

AU - Collins, Jennifer

AU - Kempe, Kristian

AU - Wilson, Paul

AU - Blindauer, Claudia A.

AU - McIntosh, Michelle P.

AU - Davis, Thomas P.

AU - Whittaker, Michael R.

AU - Haddleton, David M.

PY - 2016/8/8

Y1 - 2016/8/8

N2 - Oxytocin, a cyclic nine amino acid neurohypophyseal hormone therapeutic, is effectively used in the control of postpartum hemorrhaging (PPH) and is on the WHO List of Essential Medicines. However, oxytocin has limited shelf life stability in aqueous solutions, particularly at temperatures in excess of 25 °C and injectable aqueous oxytocin formulations require refrigeration (<8 °C). This is particularly problematic in the hot climates often found in many developing countries where daytime temperatures can exceed 40 °C and where reliable cold-chain storage is not always achievable. The purpose of this study was to develop N-terminal amine targeted PEGylation strategies utilizing both linear PEG and polyPEG "comb" polymers as an effective method for stabilizing solution formulations of this peptide for prolonged storage in the absence of efficient cold-chain storage. The conjugation chemistries investigated herein include irreversible amine targeted conjugation methods utilizing NHS ester and aldehyde reductive amination chemistry. Additionally, one reversible conjugation method using a Schiff base approach was explored to allow for the release of the native peptide, thus, ensuring that biological activity remains unaffected. The reversibility of this approach was investigated for the different polymer architectures, alongside a nonpolymer oxytocin analogue to monitor how pH can tune native peptide release. Elevated temperature degradation studies of the polymer conjugates were evaluated to assess the stability of the PEGylated analogues in comparison to the native peptide in aqueous formulations to mimic storage conditions in developing nations and regions where storage under appropriate conditions is challenging.

AB - Oxytocin, a cyclic nine amino acid neurohypophyseal hormone therapeutic, is effectively used in the control of postpartum hemorrhaging (PPH) and is on the WHO List of Essential Medicines. However, oxytocin has limited shelf life stability in aqueous solutions, particularly at temperatures in excess of 25 °C and injectable aqueous oxytocin formulations require refrigeration (<8 °C). This is particularly problematic in the hot climates often found in many developing countries where daytime temperatures can exceed 40 °C and where reliable cold-chain storage is not always achievable. The purpose of this study was to develop N-terminal amine targeted PEGylation strategies utilizing both linear PEG and polyPEG "comb" polymers as an effective method for stabilizing solution formulations of this peptide for prolonged storage in the absence of efficient cold-chain storage. The conjugation chemistries investigated herein include irreversible amine targeted conjugation methods utilizing NHS ester and aldehyde reductive amination chemistry. Additionally, one reversible conjugation method using a Schiff base approach was explored to allow for the release of the native peptide, thus, ensuring that biological activity remains unaffected. The reversibility of this approach was investigated for the different polymer architectures, alongside a nonpolymer oxytocin analogue to monitor how pH can tune native peptide release. Elevated temperature degradation studies of the polymer conjugates were evaluated to assess the stability of the PEGylated analogues in comparison to the native peptide in aqueous formulations to mimic storage conditions in developing nations and regions where storage under appropriate conditions is challenging.

UR - http://www.scopus.com/inward/record.url?scp=84981155143&partnerID=8YFLogxK

U2 - 10.1021/acs.biomac.6b00919

DO - 10.1021/acs.biomac.6b00919

M3 - Article

VL - 17

SP - 2755

EP - 2766

JO - Biomacromolecules

JF - Biomacromolecules

SN - 1525-7797

IS - 8

ER -